efavirenz has been researched along with Ataxia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Brasher, WP; Bvumbwe, M; Kazembe, PN | 1 |
Maartens, G; Martinson, NA; Mochan, A; Muchichwa, P; Norman, J; Rakgokong, M; Sigauke, FR; Variava, E | 1 |
Hauptfleisch, MP; Moore, DP; Rodda, JL | 1 |
3 other study(ies) available for efavirenz and Ataxia
Article | Year |
---|---|
Infection or drug toxicity? Acute ataxia and encephalopathy after uncomplicated falciparum malaria and efavirenz dose adjustment.
Topics: Adolescent; Alkynes; Antiretroviral Therapy, Highly Active; Ataxia; Benzoxazines; Brain Diseases; Cyclopropanes; Diplopia; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Malaria, Falciparum; Plasmodium falciparum; Reverse Transcriptase Inhibitors | 2020 |
Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series.
Topics: Adult; Alkynes; Anti-HIV Agents; Ataxia; Benzoxazines; Brain Diseases; CD4 Lymphocyte Count; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; South Africa; Tenofovir; Treatment Outcome; Viral Load; Young Adult | 2017 |
Efavirenz as a cause of ataxia in children.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Ataxia; Benzoxazines; Child; Cyclopropanes; Female; HIV Infections; HIV Seropositivity; Humans | 2015 |